ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Nocdurna Sublingual Tablets Now Available by Prescription in US
americanpharmaceuticalreview
November 10, 2018Ferring Pharmaceuticals announced the launch of Nocdurna (desmopressin acetate), the first and only sublingual tablet approved in the United States for the treatment of nocturia due to nocturnal polyuria (NP) in adults who awaken at least two times per ni -
Nocdurna Sublingual Tablets Now Available by Prescription in US
americanpharmaceuticalreview
November 10, 2018Ferring Pharmaceuticals announced the launch of Nocdurna (desmopressin acetate), the first and only sublingual tablet approved in the United States for the treatment of nocturia due to nocturnal polyuria (NP) in adults who awaken at least two times per ni
Pharma Sources Insight January 2025
